STOCK TITAN

If You Invested in Cancer Genetics Inc. (CGIX)

See the CGIX overview
CGIX has not traded since Mar 30, 2021. Its last close was $4.61, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
$1,701
+70.1% price return 70.2% CAGR
+70.1% with dividends reinvested
Bought on Mar 30, 2020 at $2.71 split-adjusted
$1,000 invested 5 Years Before Its Last Close
N/A
Comparable prices start Oct 25, 2019
$1,000 invested 10 Years Before Its Last Close
N/A
Comparable prices start Oct 25, 2019

What $1,000 or $10,000 in CGIX Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Oct 25, 2019
$1,000 $1,701 +70% — — $1,213 +21%
$10,000 $17,011 +70% — — $12,132 +21%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2021-03-30. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start CGIX on Oct 25, 2019 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.

Custom Calculation

Choose your own date and amount for CGIX

$1,000 Investment Over Time

CGIX vs S&P 500

Year-by-Year Returns

CGIX annual performance
Year Start Price End Price Annual Return Cumulative
2019Oct 25, 2019 to Dec 31, 2019 $3.80 $5.96 +56.8% +56.8%
2020 $5.96 $2.77 -53.5% -27.1%
2021Dec 31, 2020 to Mar 30, 2021 $2.77 $4.61 +66.4% +21.3%

About Cancer Genetics Inc.

Last Close
$4.61
View full CGIX overview

Frequently Asked Questions

Cancer Genetics Inc. investment returns

How much was $1,000 invested in Cancer Genetics Inc. worth at its last close?

If you invested $1,000 in Cancer Genetics Inc. (CGIX) 1 year before its last close, on 2020-03-30, your investment was worth $1,701 on 2021-03-30, a +70.1% price return without dividends, growing at a compounded rate of 70.2% per year (CAGR).

Has Cancer Genetics Inc. outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare CGIX performance over available time periods.

What is Cancer Genetics Inc.'s average annual return?

The compound annual growth rate (CAGR) of CGIX’s share price over the 1 year to Mar 30, 2021 is 70.2%, without dividends. Individual years vary a great deal, and CGIX’s best recent full year was 2020 (-53.5%) while the worst was 2020 (-53.5%).

For informational and educational purposes only, not investment advice.